$99.00
Full review →
Weight-loss management
A comprehensive health check designed for individuals using medical weight-loss treatments such as Mounjaro and Ozempic.
- Doctor reviewed
- Sample
- Blood
- Collection
- Venous draw at a partner clinic (+£35) or home visit by a phlebotomist (+£80); not available as a fi
- Results in
- 1 day
- Biomarkers
- 20
- Doctor reviewed
- Yes
Tests for
- Amylase
- Cholesterol - Total
- High-Density Lipoprotein (HDL) Cholesterol
- Low Density Lipoprotein
- Triglyceride
- HbA1c (Glycosylated Haemoglobin)
- HDL Percentage
- Estimated glomerular filtration rate (eGFR)
- Creatinine
- Sodium
- Urea
- Alkaline phosphatase
- +8 more
Test specifications
- Provider
- London Medical Laboratory
- Sample type
- blood
- Collection method
- venous draw at a partner clinic (+£35) or home visit by a phlebotomist (+£80); not available as a fi
- Turnaround time
- 1 day
- Biomarkers tested
- 20
- At-home test
- No
- Doctor reviewed
- Yes
- Gender focus
- Both
What's tested
20 biomarkers as listed by London Medical Laboratory.
Biochemistry
- Amylase
Cholesterol
- Cholesterol - Total
- High-Density Lipoprotein (HDL) Cholesterol
- Low Density Lipoprotein
- Triglyceride
Diabetes
- HbA1c (Glycosylated Haemoglobin)
Heart Health
- HDL Percentage
Kidney Function
- Estimated glomerular filtration rate (eGFR)
Kidney health
- Creatinine
- Sodium
- Urea
Liver Biochemistry Profile
- Alkaline phosphatase
Liver Function
- Alanine Transaminase
- Aspartate Aminotransferase
- Total bilirubin
Liver function
- Gamma-glutamyl transferase
Pancreas health
- Lipase
Proteins
- Albumin
- Globulin
- Total protein
About this test
A comprehensive health check designed for individuals using medical weight-loss treatments such as Mounjaro and Ozempic. This profile monitors kidney and liver function, cholesterol levels, blood sugar control, and pancreatic enzymes to help ensure safe and effective long-term use of GLP-1 medications.
What can I expect from Weight-loss management?
Weight Loss Management Blood Test - For Users of Mounjaro, Ozempic & Other GLP-1 Medications
GLP-1 receptor agonists like Mounjaro (tirzepatide) and Ozempic (semaglutide) have revolutionised weight-loss and diabetes management. However, these medications can impact multiple organs and metabolic processes, making regular monitoring essential for long-term safety and effectiveness.
This comprehensive blood test profile is specifically designed for individuals using medical weight-loss injections. It provides key insights into how your body is responding to treatment by assessing:
- Kidney function:
Creatinine, Urea, eGFR, Sodium - Important for detecting dehydration or reduced kidney function, which can be affected by rapid weight loss or medication side effects. - Liver health:
ALT, AST, ALP, GGT, Total Bilirubin, Albumin, Globulin, Total Protein - These markers monitor liver enzyme levels and protein balance, especially important as GLP-1 medications are processed by the liver and can impact liver function in some individuals. - Lipid profile (cholesterol):
Total Cholesterol, HDL, LDL, Triglycerides, HDL % - Weight-loss drugs often improve cholesterol levels, but these markers help track your cardiovascular risk as your weight changes. - Blood sugar control:
HbA1c - This long-term marker of glucose control is essential for those using GLP-1s for prediabetes, type 2 diabetes, or weight-related insulin resistance. - Pancreatic health:
Amylase, Lipase - Monitors enzymes that can be affected by GLP-1 medications, helping detect rare but serious side effects such as pancreatitis.
Who is this test for?
- Individuals currently using or planning to use GLP-1 weight-loss medications (e.g., Ozempic, Wegovy, Mounjaro)
- Those wishing to track treatment safety and effectiveness
- Patients advised by their GP or specialist to monitor organ function while on medication
Description provided by London Medical Laboratory.
